Gilmore Neil O'Neill Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gilmore Neil O'Neill.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gilmore Neil O'Neill. Gilmore Neil O'Neill is a EVP, R&D & CMO in Sarepta Therapeutics, Inc. ($SRPT) and a SVP & Chief Medical Officer in Sarepta Therapeutics, Inc. ($SRPT) and a Director in Unity Biotechnology, Inc. ($UBX).
Address: 215 FIRST STREET CAMBRIDGE 02142 MA
Companies in which Gilmore Neil O'Neill is an Insider
Sarepta Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gilmore Neil O'Neill: EVP, R&D & CMO, SVP & Chief Medical Officer
Holdings: 29,070 shares
Current Value: $847,972
Latest Transaction: Mar 05 2021
$SRPT Market Capitalization: $1.60B
$SRPT Previous Close: $29.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Unity Biotechnology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gilmore Neil O'Neill: Director
Holdings: 0 shares
Latest Transaction: Jun 28 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Gilmore Neil O'Neill
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2021 | UBX | Unity Biotechnolog ... | O'Neill Gilmore Neil | Director | Option Exercise | A | 4.18 | 13,425 | 56,117 | 13,425 | |
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Option Exercise | A | 87.11 | 60,000 | 5,226,600 | 60,000 | |
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Grant | A | 0.00 | 15,000 | 0 | 29,070 | 14.1 K to 29.1 K (+106.61 %) |
| Dec 14 2020 | UBX | Unity Biotechnolog ... | O'Neill Gilmore Neil | Director | Option Exercise | A | 6.12 | 50,000 | 306,000 | 50,000 | |
| Feb 28 2020 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Option Exercise | A | 114.47 | 37,500 | 4,292,625 | 37,500 | |
| Feb 28 2020 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Grant | A | 0.00 | 6,700 | 0 | 14,070 | 7.4 K to 14.1 K (+90.91 %) |
| May 24 2019 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Option Exercise | M | 0.00 | 12,000 | 0 | 0 |